LAZARD ASSET MANAGEMENT LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 18 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,033
-9.1%
6,500,0000.0%0.01%0.0%
Q2 2023$4,436
-61.9%
6,500,000
-56.7%
0.01%
-66.7%
Q1 2023$11,628
-33.4%
15,000,000
-34.8%
0.02%
-37.5%
Q4 2022$17,453
-99.9%
23,000,000
+1.6%
0.02%
-11.1%
Q3 2022$18,285,000
+42.1%
22,627,000
+29.3%
0.03%
+58.8%
Q2 2022$12,872,000
-41.3%
17,500,000
-32.4%
0.02%
-32.0%
Q1 2022$21,935,000
+19.3%
25,890,000
+15.1%
0.02%
+25.0%
Q4 2021$18,393,000
+25.3%
22,500,000
+15.4%
0.02%
+17.6%
Q3 2021$14,675,000
-16.4%
19,500,000
+11.4%
0.02%
-15.0%
Q2 2021$17,552,000
-24.7%
17,500,000
-22.2%
0.02%
-28.6%
Q1 2021$23,319,000
+12.2%
22,500,000
+36.4%
0.03%
+7.7%
Q4 2020$20,780,000
+24.1%
16,500,000
+17.9%
0.03%
+8.3%
Q3 2020$16,739,000
-8.1%
14,000,000
+7.7%
0.02%
-14.3%
Q2 2020$18,219,000
+5.9%
13,000,000
+8.3%
0.03%
-12.5%
Q1 2020$17,196,000
+50.4%
12,000,000
+50.0%
0.03%
+100.0%
Q4 2019$11,435,0008,000,0000.02%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Birch Grove Capital LP 9,000,000$6,561,0002.60%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 31,050,000$22,600,0000.52%
Context Capital Management, LLC 7,000$5,079,0000.36%
DeepCurrents Investment Group LLC 11,890,000$8,569,0000.34%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 25,000,000$18,139,0000.31%
CAPSTONE INVESTMENT ADVISORS, LLC 5,500,000$4,046,0000.02%
LAZARD ASSET MANAGEMENT LLC 17,500,000$12,872,0000.02%
BLB&B Advisors, LLC 100,000$73,0000.01%
MACKAY SHIELDS LLC 221,000$163,0000.00%
JPMORGAN CHASE & CO 900,000$655,0000.00%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders